Out of the Clinics, Into the Streets! Frontiers and Front Lines of Screening
The May 2023 NVHR Grassroots Advocacy Call celebrated Hepatitis Testing Day by hearing from clinics and community-based organizations around the country who are leading innovative field and street-based viral hepatitis testing.
Quarterly Hepatitis Roundtable – March 2023
The National Viral Hepatitis Roundtable and Hepatitis B Foundation hosted the first-ever Quarterly Hepatitis Roundtable on March 16, 2023. This quarter, we hosted White House advisors Francis Collins and Rachael Fleurence to discuss a national hepatitis C elimination program.
Hepatitis C: State of Medicaid Access – February 2023 Snapshot Report
Since its creation in 2017, Hepatitis C: State of Medicaid Access has evaluated hepatitis C treatment policies across state Medicaid programs. In response to advocacy and litigation, many states have reduced or eliminated their restrictions, but significant barriers remain in a majority of jurisdictions. This webinar presents our latest snapshot of the national HCV treatment landscape and our team's insights into the road that lies ahead.
State Prisons Fail to Provide Hepatitis C Treatment
During our January 2023 grassroots advocacy call we sat down with Nick Florko from STAT to discuss his investigation titled "Death Sentence" about the failure of state prisons to provide hepatitis C treatment. Read about the investigation here: https://www.statnews.com/death-sentence/
Drug Trials and Tribulations: Reflections on Equity and Access
This webinar discusses clinical trial experience as it relates to access and equity. This webinar is part TWO of a two-part series intended for patients, advocates, and other stakeholders who are interested in learning more about the clinical trial process for HBV and HDV. The webinar is co-hosted by the Hepatitis B Foundation and the National Viral Hepatitis Roundtable (NVHR).
Demystifying Drug Development: From Molecule to Medicine
This webinar provides an overview of the clinical trial process, current HBV and HDV therapies, and an introduction to interpreting clinical trial data. This webinar is part ONE of a two-part series intended for patients, advocates, and other stakeholders who are interested in learning more about the clinical trial process for HBV and HDV. The webinar is co-hosted by the Hepatitis B Foundation and the National Viral Hepatitis Roundtable (NVHR).
Hepatitis D Patient Toolkit
Hepatitis D Patient Education & Support Hepatitis D Questions and Answers for the Public, Centers for Disease Control and PreventionQuestions and answers on hepatitis D transmission, risk factors, testing, signs and symptoms, and treatment. Hepatitis Delta Connect, Hepatitis B FoundationA dedicated program of the Hepatitis B Foundation to increase awareness about hepatitis delta, to promote...
Hepatitis C Patient Toolkit
Hepatitis C Patient Education & Support What is Hepatitis C?, Centers for Disease Control and PreventionAn overview of hepatitis C transmission, risk factors, testing, signs and symptoms, and treatment. Know More Hepatitis, Centers for Disease Control and PreventionA national communications campaign promoting hepatitis C testing. Campaign materials include posters, fact sheets, radio scripts, social media...
Hepatitis B Patient Toolkit
Hepatitis B Patient Education Hepatitis B Questions and Answers for the Public, Centers for Disease Control and PreventionAn overview of hepatitis B transmission, risk factors, testing, signs and symptoms, and treatment. Hepatitis B Patient Education Resources, Centers for Disease Control and PreventionSlide sets and printable fact sheets about hepatitis B, including materials for Asian Americans,...
Hepatitis A Patient Toolkit
Hepatitis A Patient Education Hepatitis A Outbreaks, Centers for Disease Control and PreventionAn overview of hepatitis A outbreaks, including bilingual (English/Spanish) resources for the public such as fact sheets, pocket cards, and posters on people who use drugs, gay and bisexual men, people experiencing homelessness, and people who have a history of incarceration. Hepatitis A...
Hepatitis C: State of Medicaid Access – June 2022 Update
Since its creation in 2017, Hepatitis C: State of Medicaid Access has evaluated hepatitis C treatment policies across state Medicaid programs based on three criteria: liver disease severity (“fibrosis”), alcohol and drug use (“sobriety”), and prescriber limitations. In response to advocacy and litigation, these restrictions have been reduced or eliminated in many states, increasing access to lifesaving treatment. Yet significant barriers remain. Hepatitis C: State of Medicaid Access considers new and existing barriers to treatment access and dives deeper into the role that state Medicaid programs play in progressing towards a country free of viral hepatitis.
Viral Hepatitis Provider Toolkit
Resources to assist providers in the management of viral hepatitis
Hepatitis D Provider Toolkit
Hepatitis D Quick Reference Tools Hepatitis Delta Questions & Answers for Health Professionals, Centers for Disease Control and PreventionClinical information on hepatitis delta including statistics, transmission and exposure, signs and symptoms, diagnosis and treatment, and prevention. Hepatitis Delta Connect, Hepatitis B FoundationA dedicated program of the Hepatitis B Foundation to increase awareness about hepatitis delta,...
Hepatitis C Provider Toolkit
HCV Guidelines and Recommendations HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C, AASLD and IDSA CDC Recommendations for Hepatitis C Screening Among Adults (2020), Centers for Disease Control and Prevention HCV Continuing Education and Training Hepatitis C Online, University of WashingtonFree online training for diagnosing, monitoring, managing, and preventing hepatitis C virus (HCV)...
Hepatitis B Provider Toolkit
HBV Guidelines and Recommendations Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: Hepatitis B Guidance (2018), AASLD Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices (2022), Centers for Disease Control and Prevention Recommendations for Identification and Public Health Management of Persons with Chronic...
Hepatitis A Provider Toolkit
HAV Guidelines and Recommendations Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020, Centers for Disease Control and Prevention HAV Quick Reference Tools Hepatitis A Outbreaks, Centers for Disease Control and PreventionAn overview of hepatitis A outbreaks, including bilingual resources for health professionals and the...
HCV Point-of-Care Diagnostics
NVHR and Treatment Action Group (TAG) discuss what it will take to make rapid HCV diagnostics a reality in the United States. Dr. Anne Gaynor from the Association of Public Health Laboratories (APHL) walks us through the FDA announcement to reclassify HCV diagnostics.